Literature DB >> 23603393

Semaphorin 3F forms an anti-angiogenic barrier in outer retina.

Anima Buehler1, Nicholas Sitaras, Sandra Favret, Felicitas Bucher, Stefanie Berger, Amelie Pielen, Jean-Sebastian Joyal, Aimee M Juan, Gottfried Martin, Guenther Schlunck, Hansjürgen T Agostini, Michael Klagsbrun, Lois E H Smith, Przemyslaw Sapieha, Andreas Stahl.   

Abstract

Semaphorins are known modulators of axonal sprouting and angiogenesis. In the retina, we identified a distinct and almost exclusive expression of Semaphorin 3F in the outer layers. Interestingly, these outer retinal layers are physiologically avascular. Using functional in vitro models, we report potent anti-angiogenic effects of Semaphorin 3F on both retinal and choroidal vessels. In addition, human retinal pigment epithelium isolates from patients with pathologic neovascularization of the outer retina displayed reduced Semaphorin 3F expression in 10 out of 15 patients. Combined, these results elucidate a functional role for Semaphorin 3F in the outer retina where it acts as a vasorepulsive cue to maintain physiologic avascularity.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603393      PMCID: PMC4016712          DOI: 10.1016/j.febslet.2013.04.008

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Fasciclin IV: sequence, expression, and function during growth cone guidance in the grasshopper embryo.

Authors:  A L Kolodkin; D J Matthes; T P O'Connor; N H Patel; A Admon; D Bentley; C S Goodman
Journal:  Neuron       Date:  1992-11       Impact factor: 17.173

2.  Retinal angiomatous proliferation in age-related macular degeneration.

Authors:  L A Yannuzzi; S Negrão; T Iida; C Carvalho; H Rodriguez-Coleman; J Slakter; K B Freund; J Sorenson; D Orlock; N Borodoker
Journal:  Retina       Date:  2001       Impact factor: 4.256

3.  Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture.

Authors:  Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

4.  Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro.

Authors:  A Stahl; L Paschek; G Martin; N J Gross; N Feltgen; L L Hansen; H T Agostini
Journal:  FEBS Lett       Date:  2008-08-12       Impact factor: 4.124

Review 5.  Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.

Authors:  Eugene W M Ng; Anthony P Adamis
Journal:  Can J Ophthalmol       Date:  2005-06       Impact factor: 1.882

6.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  Plexin A3 is involved in semaphorin 3F-mediated oligodendrocyte precursor cell migration.

Authors:  Xin Xiang; Xuan Zhang; Qi-Lin Huang
Journal:  Neurosci Lett       Date:  2012-10-11       Impact factor: 3.046

8.  Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones.

Authors:  Y Luo; D Raible; J A Raper
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 9.  The semaphorins: versatile regulators of tumour progression and tumour angiogenesis.

Authors:  Gera Neufeld; Ofra Kessler
Journal:  Nat Rev Cancer       Date:  2008-06-26       Impact factor: 60.716

10.  Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation.

Authors:  T Korff; H G Augustin
Journal:  J Cell Biol       Date:  1998-11-30       Impact factor: 10.539

View more
  24 in total

1.  Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility.

Authors:  Vera Procaccia; Hironao Nakayama; Akio Shimizu; Michael Klagsbrun
Journal:  Biochem Biophys Res Commun       Date:  2014-04-20       Impact factor: 3.575

Review 2.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

Review 3.  The role of the semaphorins in cancer.

Authors:  Gera Neufeld; Yelena Mumblat; Tatyana Smolkin; Shira Toledano; Inbal Nir-Zvi; Keren Ziv; Ofra Kessler
Journal:  Cell Adh Migr       Date:  2016-08-17       Impact factor: 3.405

4.  Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F.

Authors:  Hou-Fu Guo; Xiaobo Li; Matthew W Parker; Johannes Waltenberger; Patrice M Becker; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2013-10-18       Impact factor: 3.162

5.  RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.

Authors:  Ye Sun; Chi-Hsiu Liu; Zhongxiao Wang; Steven S Meng; Samuel B Burnim; John Paul SanGiovanni; Theodore M Kamenecka; Laura A Solt; Jing Chen
Journal:  FASEB J       Date:  2017-06-23       Impact factor: 5.191

6.  Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations.

Authors:  M M Koczorowska; S Tholen; F Bucher; L Lutz; J N Kizhakkedathu; O De Wever; U F Wellner; M L Biniossek; A Stahl; S Lassmann; O Schilling
Journal:  Mol Oncol       Date:  2015-08-11       Impact factor: 6.603

Review 7.  Emerging Insights and Interventions for Diabetic Retinopathy.

Authors:  Avinash Honasoge; Eric Nudleman; Morton Smith; Rithwick Rajagopal
Journal:  Curr Diab Rep       Date:  2019-09-10       Impact factor: 4.810

8.  β-adrenergic receptor-dependent alterations in murine cardiac transcript expression are differentially regulated by gefitinib in vivo.

Authors:  Jennifer A Talarico; Rhonda L Carter; Laurel A Grisanti; Justine E Yu; Ashley A Repas; Douglas G Tilley
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

9.  Changes in expression of Class 3 Semaphorins and their receptors during development of the rat retina and superior colliculus.

Authors:  Anil Sharma; Chrisna J LeVaillant; Giles W Plant; Alan R Harvey
Journal:  BMC Dev Biol       Date:  2014-07-26       Impact factor: 1.978

10.  Refuting the hypothesis that semaphorin-3f/neuropilin-2 exclude blood vessels from the cap mesenchyme in the developing kidney.

Authors:  David A D Munro; Peter Hohenstein; Thomas M Coate; Jamie A Davies
Journal:  Dev Dyn       Date:  2017-10-13       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.